 | • レポートコード：QYR2104Z1827 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、糖尿病性足潰瘍（DFU）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（事前創傷被覆材、代用皮膚、陰圧閉鎖療法装置、成長因子）、用途別市場規模（病院、専門クリニック、介護センター、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・糖尿病性足潰瘍（DFU）治療の市場動向 ・企業の競争状況、市場シェア ・糖尿病性足潰瘍（DFU）治療の種類別市場規模（事前創傷被覆材、代用皮膚、陰圧閉鎖療法装置、成長因子） ・糖尿病性足潰瘍（DFU）治療の用途別市場規模（病院、専門クリニック、介護センター、外来手術センター） ・糖尿病性足潰瘍（DFU）治療の北米市場規模2016-2027（アメリカ、カナダ） ・糖尿病性足潰瘍（DFU）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・糖尿病性足潰瘍（DFU）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・糖尿病性足潰瘍（DFU）治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・糖尿病性足潰瘍（DFU）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（B.Braun Melsungen、Smith & Nephew、Organogenesis、Derma Sciences、Sigvaris、3M、Acelity、Innocoll Holdings、SIGVARIS、Osiris） ・結論 |
Major market players in the global diabetic foot ulcer therapeutics market are introducing innovative and expanded line products to retain their global market share. Over the last few decades, an increasing number of diabetic foot ulcer therapeutics manufacturers have been focusing on introducing breakthrough advanced wound dressings for diabetic foot ulcer management. This includes novel dressings with the ability to confer moisture balance with prolonged time of action, extended oxygen permeability, antimicrobial activity, growth factor stimulation, and the ability to promote autolytic debridement thus facilitating the re-epithelialization process. This factor is creating robust development in the global diabetic foot ulcer therapeutics market.
A growing population affected by diabetes and a subsequent increase in the number of people afflicted with diabetic foot ulcer is likely to impact the global diabetic foot ulcer therapeutics market in a positive manner over the forecast period. Furthermore, continued prioritization to avoid surgeries and amputations is expected to fuel the growth of the global diabetic foot ulcer therapeutics market over the predicted period. Diabetes mellitus is one of the most important public health concerns worldwide, with an increased risk of developing diabetic foot ulcer. Hence, a number of clinical trials are being conducted currently wherein a large number of organizations are actively participating in extended research programs to develop novel therapies for diabetic foot ulcer treatment. Individuals with an increased risk of diabetes are demonstrating alarming hospitalization rates as a result of diabetes foot ulcer infection. This has resulted in a rise in the number of amputations. The occurrence of diabetes and associated risk factors are increasing at an alarming rate, which is expected to fuel revenue growth of the global diabetic foot ulcer therapeutics market during the period of assessment.
Market Analysis and Insights: Global Diabetic Foot Ulcer Therapeutics Market
The global Diabetic Foot Ulcer Therapeutics market size is projected to reach US$ 6463.6 million by 2026, from US$ 4057.6 million in 2019, at a CAGR of 6.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diabetic Foot Ulcer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diabetic Foot Ulcer Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diabetic Foot Ulcer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diabetic Foot Ulcer Therapeutics market.
Global Diabetic Foot Ulcer Therapeutics Scope and Market Size
Diabetic Foot Ulcer Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diabetic Foot Ulcer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Advance Wound Dressings
Skin Substitutes
Negative Pressure Wound Therapy Devices
Growth Factors
Segment by Application
Hospitals
Specialty Clinics
Long-Term Care Centers
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
B.Braun Melsungen
Smith & Nephew
Organogenesis
Derma Sciences
Sigvaris
3M
Acelity
Innocoll Holdings
SIGVARIS
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Foot Ulcer Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Advance Wound Dressings
1.2.3 Skin Substitutes
1.2.4 Negative Pressure Wound Therapy Devices
1.2.5 Growth Factors
1.3 Market by Application
1.3.1 Global Diabetic Foot Ulcer Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Long-Term Care Centers
1.3.5 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Foot Ulcer Therapeutics Market Perspective (2016-2027)
2.2 Diabetic Foot Ulcer Therapeutics Growth Trends by Regions
2.2.1 Diabetic Foot Ulcer Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diabetic Foot Ulcer Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Diabetic Foot Ulcer Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Diabetic Foot Ulcer Therapeutics Industry Dynamic
2.3.1 Diabetic Foot Ulcer Therapeutics Market Trends
2.3.2 Diabetic Foot Ulcer Therapeutics Market Drivers
2.3.3 Diabetic Foot Ulcer Therapeutics Market Challenges
2.3.4 Diabetic Foot Ulcer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Foot Ulcer Therapeutics Players by Revenue
3.1.1 Global Top Diabetic Foot Ulcer Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Diabetic Foot Ulcer Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Diabetic Foot Ulcer Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diabetic Foot Ulcer Therapeutics Revenue
3.4 Global Diabetic Foot Ulcer Therapeutics Market Concentration Ratio
3.4.1 Global Diabetic Foot Ulcer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Foot Ulcer Therapeutics Revenue in 2020
3.5 Diabetic Foot Ulcer Therapeutics Key Players Head office and Area Served
3.6 Key Players Diabetic Foot Ulcer Therapeutics Product Solution and Service
3.7 Date of Enter into Diabetic Foot Ulcer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Foot Ulcer Therapeutics Breakdown Data by Type
4.1 Global Diabetic Foot Ulcer Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Diabetic Foot Ulcer Therapeutics Forecasted Market Size by Type (2022-2027)
5 Diabetic Foot Ulcer Therapeutics Breakdown Data by Application
5.1 Global Diabetic Foot Ulcer Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Diabetic Foot Ulcer Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Diabetic Foot Ulcer Therapeutics Market Size (2016-2027)
6.2 North America Diabetic Foot Ulcer Therapeutics Market Size by Type
6.2.1 North America Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2027)
6.3 North America Diabetic Foot Ulcer Therapeutics Market Size by Application
6.3.1 North America Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2027)
6.4 North America Diabetic Foot Ulcer Therapeutics Market Size by Country
6.4.1 North America Diabetic Foot Ulcer Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Diabetic Foot Ulcer Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Diabetic Foot Ulcer Therapeutics Market Size (2016-2027)
7.2 Europe Diabetic Foot Ulcer Therapeutics Market Size by Type
7.2.1 Europe Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2027)
7.3 Europe Diabetic Foot Ulcer Therapeutics Market Size by Application
7.3.1 Europe Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2027)
7.4 Europe Diabetic Foot Ulcer Therapeutics Market Size by Country
7.4.1 Europe Diabetic Foot Ulcer Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Diabetic Foot Ulcer Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Type
8.2.1 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Application
8.3.1 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Region
8.4.1 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Diabetic Foot Ulcer Therapeutics Market Size (2016-2027)
9.2 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Type
9.2.1 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Application
9.3.1 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Country
9.4.1 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Diabetic Foot Ulcer Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Type
10.2.1 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Application
10.3.1 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Country
10.4.1 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 B.Braun Melsungen
11.1.1 B.Braun Melsungen Company Details
11.1.2 B.Braun Melsungen Business Overview
11.1.3 B.Braun Melsungen Diabetic Foot Ulcer Therapeutics Introduction
11.1.4 B.Braun Melsungen Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.1.5 B.Braun Melsungen Recent Development
11.2 Smith & Nephew
11.2.1 Smith & Nephew Company Details
11.2.2 Smith & Nephew Business Overview
11.2.3 Smith & Nephew Diabetic Foot Ulcer Therapeutics Introduction
11.2.4 Smith & Nephew Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.2.5 Smith & Nephew Recent Development
11.3 Organogenesis
11.3.1 Organogenesis Company Details
11.3.2 Organogenesis Business Overview
11.3.3 Organogenesis Diabetic Foot Ulcer Therapeutics Introduction
11.3.4 Organogenesis Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.3.5 Organogenesis Recent Development
11.4 Derma Sciences
11.4.1 Derma Sciences Company Details
11.4.2 Derma Sciences Business Overview
11.4.3 Derma Sciences Diabetic Foot Ulcer Therapeutics Introduction
11.4.4 Derma Sciences Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.4.5 Derma Sciences Recent Development
11.5 Sigvaris
11.5.1 Sigvaris Company Details
11.5.2 Sigvaris Business Overview
11.5.3 Sigvaris Diabetic Foot Ulcer Therapeutics Introduction
11.5.4 Sigvaris Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.5.5 Sigvaris Recent Development
11.6 3M
11.6.1 3M Company Details
11.6.2 3M Business Overview
11.6.3 3M Diabetic Foot Ulcer Therapeutics Introduction
11.6.4 3M Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.6.5 3M Recent Development
11.7 Acelity
11.7.1 Acelity Company Details
11.7.2 Acelity Business Overview
11.7.3 Acelity Diabetic Foot Ulcer Therapeutics Introduction
11.7.4 Acelity Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.7.5 Acelity Recent Development
11.8 Innocoll Holdings
11.8.1 Innocoll Holdings Company Details
11.8.2 Innocoll Holdings Business Overview
11.8.3 Innocoll Holdings Diabetic Foot Ulcer Therapeutics Introduction
11.8.4 Innocoll Holdings Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.8.5 Innocoll Holdings Recent Development
11.9 SIGVARIS
11.9.1 SIGVARIS Company Details
11.9.2 SIGVARIS Business Overview
11.9.3 SIGVARIS Diabetic Foot Ulcer Therapeutics Introduction
11.9.4 SIGVARIS Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.9.5 SIGVARIS Recent Development
11.10 Osiris
11.10.1 Osiris Company Details
11.10.2 Osiris Business Overview
11.10.3 Osiris Diabetic Foot Ulcer Therapeutics Introduction
11.10.4 Osiris Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
11.10.5 Osiris Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Diabetic Foot Ulcer Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Advance Wound Dressings
Table 3. Key Players of Skin Substitutes
Table 4. Key Players of Negative Pressure Wound Therapy Devices
Table 5. Key Players of Growth Factors
Table 6. Global Diabetic Foot Ulcer Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Diabetic Foot Ulcer Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Diabetic Foot Ulcer Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Diabetic Foot Ulcer Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Diabetic Foot Ulcer Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Diabetic Foot Ulcer Therapeutics Market Share by Regions (2022-2027)
Table 12. Diabetic Foot Ulcer Therapeutics Market Trends
Table 13. Diabetic Foot Ulcer Therapeutics Market Drivers
Table 14. Diabetic Foot Ulcer Therapeutics Market Challenges
Table 15. Diabetic Foot Ulcer Therapeutics Market Restraints
Table 16. Global Diabetic Foot Ulcer Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Diabetic Foot Ulcer Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Diabetic Foot Ulcer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Foot Ulcer Therapeutics as of 2020)
Table 19. Ranking of Global Top Diabetic Foot Ulcer Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Diabetic Foot Ulcer Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Diabetic Foot Ulcer Therapeutics Product Solution and Service
Table 23. Date of Enter into Diabetic Foot Ulcer Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Diabetic Foot Ulcer Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Diabetic Foot Ulcer Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Diabetic Foot Ulcer Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Diabetic Foot Ulcer Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Diabetic Foot Ulcer Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Diabetic Foot Ulcer Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Diabetic Foot Ulcer Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Diabetic Foot Ulcer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Diabetic Foot Ulcer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Diabetic Foot Ulcer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Diabetic Foot Ulcer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Diabetic Foot Ulcer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Diabetic Foot Ulcer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. B.Braun Melsungen Company Details
Table 64. B.Braun Melsungen Business Overview
Table 65. B.Braun Melsungen Diabetic Foot Ulcer Therapeutics Product
Table 66. B.Braun Melsungen Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021) & (US$ Million)
Table 67. B.Braun Melsungen Recent Development
Table 68. Smith & Nephew Company Details
Table 69. Smith & Nephew Business Overview
Table 70. Smith & Nephew Diabetic Foot Ulcer Therapeutics Product
Table 71. Smith & Nephew Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Smith & Nephew Recent Development
Table 73. Organogenesis Company Details
Table 74. Organogenesis Business Overview
Table 75. Organogenesis Diabetic Foot Ulcer Therapeutics Product
Table 76. Organogenesis Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Organogenesis Recent Development
Table 78. Derma Sciences Company Details
Table 79. Derma Sciences Business Overview
Table 80. Derma Sciences Diabetic Foot Ulcer Therapeutics Product
Table 81. Derma Sciences Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Derma Sciences Recent Development
Table 83. Sigvaris Company Details
Table 84. Sigvaris Business Overview
Table 85. Sigvaris Diabetic Foot Ulcer Therapeutics Product
Table 86. Sigvaris Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Sigvaris Recent Development
Table 88. 3M Company Details
Table 89. 3M Business Overview
Table 90. 3M Diabetic Foot Ulcer Therapeutics Product
Table 91. 3M Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021) & (US$ Million)
Table 92. 3M Recent Development
Table 93. Acelity Company Details
Table 94. Acelity Business Overview
Table 95. Acelity Diabetic Foot Ulcer Therapeutics Product
Table 96. Acelity Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021) & (US$ Million)
Table 97. Acelity Recent Development
Table 98. Innocoll Holdings Company Details
Table 99. Innocoll Holdings Business Overview
Table 100. Innocoll Holdings Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021) & (US$ Million)
Table 101. Innocoll Holdings Recent Development
Table 102. SIGVARIS Company Details
Table 103. SIGVARIS Business Overview
Table 104. SIGVARIS Diabetic Foot Ulcer Therapeutics Product
Table 105. SIGVARIS Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021) & (US$ Million)
Table 106. SIGVARIS Recent Development
Table 107. Osiris Company Details
Table 108. Osiris Business Overview
Table 109. Osiris Diabetic Foot Ulcer Therapeutics Product
Table 110. Osiris Revenue in Diabetic Foot Ulcer Therapeutics Business (2016-2021) & (US$ Million)
Table 111. Osiris Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Foot Ulcer Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Advance Wound Dressings Features
Figure 3. Skin Substitutes Features
Figure 4. Negative Pressure Wound Therapy Devices Features
Figure 5. Growth Factors Features
Figure 6. Global Diabetic Foot Ulcer Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Long-Term Care Centers Case Studies
Figure 10. Ambulatory Surgical Centers Case Studies
Figure 11. Diabetic Foot Ulcer Therapeutics Report Years Considered
Figure 12. Global Diabetic Foot Ulcer Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Diabetic Foot Ulcer Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Diabetic Foot Ulcer Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Diabetic Foot Ulcer Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Diabetic Foot Ulcer Therapeutics Market Share by Players in 2020
Figure 17. Global Top Diabetic Foot Ulcer Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diabetic Foot Ulcer Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Diabetic Foot Ulcer Therapeutics Revenue in 2020
Figure 19. Global Diabetic Foot Ulcer Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Diabetic Foot Ulcer Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Diabetic Foot Ulcer Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Diabetic Foot Ulcer Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Diabetic Foot Ulcer Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Diabetic Foot Ulcer Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Diabetic Foot Ulcer Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Diabetic Foot Ulcer Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Diabetic Foot Ulcer Therapeutics Market Share by Region (2016-2027)
Figure 41. China Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Diabetic Foot Ulcer Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Diabetic Foot Ulcer Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Diabetic Foot Ulcer Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Diabetic Foot Ulcer Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Diabetic Foot Ulcer Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. B.Braun Melsungen Revenue Growth Rate in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
Figure 61. Smith & Nephew Revenue Growth Rate in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
Figure 62. Organogenesis Revenue Growth Rate in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
Figure 63. Derma Sciences Revenue Growth Rate in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
Figure 64. Sigvaris Revenue Growth Rate in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
Figure 65. 3M Revenue Growth Rate in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
Figure 66. Acelity Revenue Growth Rate in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
Figure 67. Innocoll Holdings Revenue Growth Rate in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
Figure 68. SIGVARIS Revenue Growth Rate in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
Figure 69. Osiris Revenue Growth Rate in Diabetic Foot Ulcer Therapeutics Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
世界の糖尿病性足潰瘍（DFU）治療製品市場規模・現状・予測（2021年-2027年） Diabetic foot ulcer is a major complication of diabetes mellitus, and probably the major component of the diabetic foot. Diabetic foot ulcers are among one of the major global medical issues. Management of diabetic foot ulcers aims at fast healing and wound closure, by adopting a multidisciplinary t…- 世界の糖尿病性足潰瘍治療市場 2021：企業別、地域別、種類・用途別 The Diabetic Foot Ulcers Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …
- 世界の先進創傷ケア市場規模・現状・予測（2021年-2027年） Advanced Wound Care products for the wound healing process are generally prescribed by clinicians after a visit to the doctor or hospital. Advanced Wound Care products generally includes film and foam dressings, hydrogels, alginates and hydrocolloids. Such products are largely focused on keeping the…
- 世界の使い捨て陰圧閉鎖療法（NPWT）用装置市場 2021：企業別、地域別、種類・用途別 The Single-use Negative Pressure Wound Therapy (NPWT) Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value…
- 世界のコラーゲン創傷被覆材市場規模・現状・予測（2021年-2027年） Collagen wound dressings are gels, pads, particles, pastes, powders, sheets or solutions derived from bovine, equine, porcine or avian sources. Some interact with wound exudate to form a gel. Indicated for partial- and full-thickness pressure ulcers, venous ulcers, donor sites, surgical wounds, vasc…